Commonwealth Equity Services’s Aquestive Therapeutics AQST Stock Holding History

Commonwealth Equity Services’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.73M	Sell	1,020,988 -25,187	-2%	-$112K	0.01%	1398
2026 Q2	$4.35M	Sell	1,046,175 -36,505	-3%	-$154K	0.01%	1517
2026 Q1	$4.49M	Buy	1,082,680 +62,888	+6%	+$255K	0.01%	1406
2025 Q4	$6.59M	Sell	1,019,792 -38,933	-4%	-$243K	0.01%	1138
2025 Q3	$5.92M	Buy	+1,058,725	New	+$4.58M	0.01%	1223

Other funds holding AQST

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Sugar Maple Asset Management Sister Bay, Wisconsin $175M AUM 16.33% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Trust Point Inc La Crosse, Wisconsin $1.33B AUM 20.56% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Commonwealth Equity Services's AQST Position: Q3 2026 in Review

Commonwealth Equity Services reduced its Aquestive Therapeutics (AQST) stake by 2.4% in Q3 2026, selling an estimated $112K and leaving 1,020,988 shares worth $4.73M. The position accounts for 0.01% of the portfolio, ranked #1398.

Commonwealth Equity Services first reported a position in AQST in Q3 2025 and has held it in 5 quarters since. The position peaked at $6.59M in Q4 2025. 42 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

Commonwealth Equity Services held 1,020,988 shares of Aquestive Therapeutics worth $4.73M as of Q3 2026.
Commonwealth Equity Services sold 25,187 Aquestive Therapeutics shares in Q3 2026, an estimated $112K.
Aquestive Therapeutics made up 0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #1398 holding.
Commonwealth Equity Services first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 5 quarters since.
Commonwealth Equity Services's Aquestive Therapeutics position peaked at $6.59M in Q4 2025.
42 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.